Icahn Capital 13F holdings, Q1 2010
Holdings as of March 31, 2010 · filings on SEC EDGAR · latest filing →
Icahn Capital disclosed 15 US equity positions worth $2.8bn in its Q1 2010 13F filing. The largest position was MOTOROLA INC at 38.9% of the reported book, followed by BIIB and GENZYME CORP. Against the Q4 2009 filing, it opened 1 new position, added to 4 and reduced 1 among the top 15 holdings.
What did Icahn Capital own in Q1 2010? Top 15 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2009 |
|---|---|---|---|---|---|---|---|
| 1 | MOTOROLA INC | 38.9% | $1.1bn | 156,220,000 | 30% | added | |
| 2 | BIIB BIOGEN IDEC INC | Healthcare | 26.1% | $737.7m | 12,860,205 | 0% | held |
| 3 | GENZYME CORP | 19.2% | $543.2m | 10,480,000 | 118% | added | |
| 4 | LIONS GATE ENTMNT CORP | 3.9% | $109.7m | 17,581,750 | 6% | added | |
| 5 | TTWO TAKE-TWO INTERACTIVE SOFTWARE | Communication Services | 3.2% | $91.6m | 9,296,422 | 39% | added |
| 6 | YAHOO INC | 2.4% | $66.8m | 4,041,363 | -66% | reduced | |
| 7 | CHESAPEAKE ENERGY CORP | 1.8% | $50.2m | 2,122,949 | – | new | |
| 8 | CYBERONICS INC | 1.4% | $40.4m | 2,107,972 | 0% | held | |
| 9 | FOREST LABS INC | 1.3% | $38.0m | 1,213,120 | 0% | held | |
| 10 | ENZON PHARMACEUTICALS INC | 1.0% | $28.7m | 2,816,861 | 0% | held | |
| 11 | EXEL EXELIXIS INC | Healthcare | 0.5% | $14.3m | 2,357,110 | 0% | held |
| 12 | WENDYS ARBYS GROUP INC | 0.1% | $3.2m | 643,590 | 0% | held | |
| 13 | LIONS GATE ENTMNT CORP | 0.0% | $884.0k | 923,200 | 0% | held | |
| 14 | ADVENTRX PHARMACEUTICALS INC | 0.0% | $753.0k | 3,459,459 | 0% | held | |
| 15 | LIONS GATE ENTMNT CORP | 0.0% | $327.0k | 343,200 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.